These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12803479)

  • 1. Differentiation of CD34+ cells from human cord blood and murine bone marrow is suppressed by C6 beta-chemokines.
    Han IS; Ra JS; Kim MW; Lee EA; Jun HY; Park SK; Kwon BS
    Mol Cells; 2003 Apr; 15(2):176-80. PubMed ID: 12803479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CKbeta8-1 alters expression of cyclin E in colony forming units-granulocyte macrophage (CFU-GM) lineage from human cord blood CD34+ cells.
    Noh EK; Ra JS; Lee SA; Kwon BS; Han IS
    Exp Mol Med; 2005 Dec; 37(6):619-23. PubMed ID: 16391523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressive effects of TNF-alpha, TGF-beta1, and chemokines on megakaryocytic colony formation in CD34+ cells derived from umbilical cord blood compared with mobilized peripheral blood and bone marrow.
    Lu L; Wang LS; Cooper RJ; Liu HJ; Turner K; Weich N; Broxmeyer HE
    J Hematother Stem Cell Res; 2000 Apr; 9(2):195-204. PubMed ID: 10813532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-derived macrophage layers in the presence of hydrocortisone support myeloid progenitors in long-term cultures of CD34+ cord blood and bone marrow cells.
    Clausen J; Stockschläder M; Fehse N; Hassan HT; Gabl C; Zander AR
    Ann Hematol; 2000 Feb; 79(2):59-65. PubMed ID: 10741916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 (CD135) receptor tyrosine kinase.
    Rappold I; Ziegler BL; Köhler I; Marchetto S; Rosnet O; Birnbaum D; Simmons PJ; Zannettino AC; Hill B; Neu S; Knapp W; Alitalo R; Alitalo K; Ullrich A; Kanz L; Bühring HJ
    Blood; 1997 Jul; 90(1):111-25. PubMed ID: 9207445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of leukotactin-1 on the protection in vivo of myeloid progenitor cells against cytotoxic chemotherapeutics.
    Kim WY; Broxmeyer HE; Han IS; Park DH; Lee KM; Vinay DS; Kwon BS
    J Hematother Stem Cell Res; 2003 Feb; 12(1):107-13. PubMed ID: 12662441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative and qualitative differences in thrombopoietin-dependent hematopoietic progenitor development between cord blood and bone marrow.
    Mwamtemi HH; Higuchi T; Sawai N; Hidaka E; Koike K
    Transplantation; 2000 Apr; 69(8):1645-54. PubMed ID: 10836376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the in vitro behavior of phenotypically defined populations of umbilical cord blood hematopoietic progenitor cells.
    Traycoff CM; Abboud MR; Laver J; Brandt JE; Hoffman R; Law P; Ishizawa L; Srour EF
    Exp Hematol; 1994 Feb; 22(2):215-22. PubMed ID: 7507862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct growth suppression of myeloid bone marrow progenitor cells but not cord blood progenitors by human cytomegalovirus in vitro.
    Holberg-Petersen M; Rollag H; Beck S; Overli I; Tjønnfjord G; Abrahamsen TG; Degré M; Hestdal K
    Blood; 1996 Oct; 88(7):2510-6. PubMed ID: 8839843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of CD34+ subsets and clonogenicity in human bone marrow, granulocyte colony-stimulating factor-mobilized peripheral blood, and cord blood.
    Cho SH; Chung IJ; Lee JJ; Park ML; Kim HJ
    J Korean Med Sci; 1999 Oct; 14(5):520-5. PubMed ID: 10576147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine-dependent ex vivo expansion of early subsets of CD34+ cord blood myeloid progenitors is enhanced by cord blood plasma, but expansion of the more mature subsets of progenitors is favored.
    Ruggieri L; Heimfeld S; Broxmeyer HE
    Blood Cells; 1994; 20(2-3):436-54. PubMed ID: 7538350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo expansion and clonality of CD34+ selected cells from bone marrow and cord blood in a serum-free media.
    Kim SK; Koh SK; Song SU; Shin SH; Choi GS; Kim WC; Lee MH; Seoh JY; Park SK; Fraser JK
    Mol Cells; 2002 Dec; 14(3):367-73. PubMed ID: 12521299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential response of CD34+ cells isolated from cord blood and bone marrow to MIP-1 alpha and the expression of MIP-1 alpha receptors on these immature cells.
    de Wynter EA; Durig J; Cross MA; Heyworth CM; Testa NG
    Stem Cells; 1998; 16(5):349-56. PubMed ID: 9766815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The composition of CD34 subpopulations differs between bone marrow, blood and cord blood.
    Fritsch G; Stimpfl M; Kurz M; Printz D; Buchinger P; Fischmeister G; Hoecker P; Gadner H
    Bone Marrow Transplant; 1996 Feb; 17(2):169-78. PubMed ID: 8640162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human chemokines: enhancement of specific activity and effects in vitro on normal and leukemic progenitors and a factor-dependent cell line and in vivo in mice.
    Broxmeyer HE; Cooper S; Hague N; Benninger L; Sarris A; Cornetta K; Vadhan-Raj S; Hendrie P; Mantel C
    Ann Hematol; 1995 Nov; 71(5):235-46. PubMed ID: 7492626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of murine mast cell growth factor (c-kit proto-oncogene ligand) on colony formation by human marrow hematopoietic progenitor cells.
    Broxmeyer HE; Cooper S; Lu L; Hangoc G; Anderson D; Cosman D; Lyman SD; Williams DE
    Blood; 1991 May; 77(10):2142-9. PubMed ID: 1709371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Differences in megakaryocyte progenitor ex vivo expansion between CD34+ cells derived from human umbilical cord blood and bone marrow].
    He Y; Meng HX; Zhang YG; Hou SF; Wang H; Huang Y; Li Q; Han JL; Qiu LG; Han ZC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1398-402. PubMed ID: 19099652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The limited infectability by R5 HIV of CD34(+) cells from thymus, cord, and peripheral blood and bone marrow is explained by their ability to produce beta-chemokines.
    Majka M; Rozmyslowicz T; Ratajczak J; Dobrowsky A; Pietrzkowski Z; Gaulton GN; Janowska-Wieczorek A; Ratajczak MZ
    Exp Hematol; 2000 Dec; 28(12):1334-42. PubMed ID: 11146155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. Interacting effects involving suppression, synergistic suppression, and blocking of suppression.
    Broxmeyer HE; Sherry B; Cooper S; Lu L; Maze R; Beckmann MP; Cerami A; Ralph P
    J Immunol; 1993 Apr; 150(8 Pt 1):3448-58. PubMed ID: 7682242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood.
    Aiuti A; Webb IJ; Bleul C; Springer T; Gutierrez-Ramos JC
    J Exp Med; 1997 Jan; 185(1):111-20. PubMed ID: 8996247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.